ModelEdge

Regeneron Pharmaceuticals, Inc.
REGN
Filing Type10-K
Filing Date2/4/2024
Updated2/5/24, 2:16 AM

Filing

10-K
Earnings Release

Exhibits

10-KFY 2023
EX-10.3 6STOCK OPTION AGREEMENT (NQ) - EXECUTIVE OFFICERS
EX-10.3 7RESTRICTED STOCK AGREEMENT - EXECUTIVE OFFICERS
EX-21.1SUBSIDIARIES OF THE REGISTRANT
EX-23.1CONSENT OF PRICEWATERHOUSECOOPERS LLP
EX-31.1CERTIFICATION OF CEO PURSUANT TO RULE 13A-14(A)
EX-31.2CERTIFICATION OF CFO PURSUANT TO RULE 13A-14(A)
EX-32CERTIFICATION OF CEO AND CFO PURSUANT TO 18 U.S.C. SECTION 1350
EX-97.1CLAWBACK POLICY
GRAPHIC